Journal list menu
Export Citations
Download PDFs
Comments from the Editors
Free Access
free
Efficacy, effectiveness, and comparative effectiveness in liver disease†
- Pages: 403-407
- First Published: 23 July 2010
Editorial
Free Access
free
New insights into the role of iron in the development of nonalcoholic fatty liver disease†‡
- Pages: 408-410
- First Published: 23 July 2010
Viral Hepatitis
Free Access
free
Involvement of PA28γ in the propagation of hepatitis C virus†
- Pages: 411-420
- First Published: 23 July 2010
Free Access
free
Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin†
- Pages: 421-429
- First Published: 23 July 2010
Free Access
free
Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C†
- Pages: 430-435
- First Published: 23 July 2010
Free Access
free
The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs†
- Pages: 436-442
- First Published: 23 July 2010
Open Access
oa
Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro†‡§
- Pages: 443-453
- First Published: 23 July 2010
Free Access
free
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels†
- Pages: 454-461
- First Published: 23 July 2010
Steatohepatitis/Metabolic Liver Disease
Free Access
free
Hepatic iron loading in mice increases cholesterol biosynthesis†
- Pages: 462-471
- First Published: 23 July 2010
Free Access
free
High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial†
- Pages: 472-479
- First Published: 23 July 2010
Hepatobiliary Malignancies
Free Access
free
c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide–dependent impairment of oxidative DNA repair†
- Pages: 480-492
- First Published: 23 July 2010
Free Access
free
Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus–transgenic mice by peroxisome proliferator-activated receptor γ–independent regulation of nucleophosmin†
- Pages: 493-505
- First Published: 23 July 2010
Free Access
free
Synergistic role of sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis†
- Pages: 506-517
- First Published: 23 July 2010
Free Access
free
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection†
- Pages: 518-527
- First Published: 23 July 2010
Free Access
free
Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP-binding cassette G2 pathway†
- Pages: 528-539
- First Published: 23 July 2010
Free Access
free
Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: A role for angiopoietin-1†
- Pages: 540-549
- First Published: 23 July 2010
Free Access
free
A smac mimetic reduces TNF Related Apoptosis Inducing Ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells†
- Pages: 550-561
- First Published: 23 July 2010
Autoimmune, Cholestatic and Biliary Disease
Free Access
free
The specificity of fatigue in primary biliary cirrhosis: Evaluation of a large clinic practice†
- Pages: 562-570
- First Published: 23 July 2010
Free Access
free
Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in sweden†
- Pages: 571-577
- First Published: 23 July 2010
Liver Failure/Cirrhosis/Portal Hypertension
Free Access
free
Association between serum uric acid level and chronic liver disease in the United States†
- Pages: 578-589
- First Published: 23 July 2010
Free Access
free
Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver†
- Pages: 590-601
- First Published: 23 July 2010
Liver Injury/Regeneration
Free Access
free
Cytosolic calcium regulates liver regeneration in the rat†
- Pages: 602-611
- First Published: 23 July 2010
Liver Biology/Pathobiology
Free Access
free
Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: Implications for the pathogenesis of HIV/hepatitis C virus–induced liver fibrosis†
- Pages: 612-622
- First Published: 23 July 2010
Free Access
free
Lipid rafts are essential for peroxisome biogenesis in HepG2 cells†
- Pages: 623-633
- First Published: 23 July 2010
Free Access
free
Quantifying growth and transformation frequency of oncogene-expressing mouse hepatocytes in vivo†
- Pages: 634-643
- First Published: 23 July 2010
Free Access
free
Cytosolic phospholipase A2α and peroxisome proliferator-activated receptor γ signaling pathway counteracts transforming growth factor β–mediated inhibition of primary and transformed hepatocyte growth†
- Pages: 644-655
- First Published: 23 July 2010
Free Access
free
Glycosylation of fibroblast growth factor receptor 4 is a key regulator of fibroblast growth factor 19–mediated down-regulation of cytochrome P450 7A1†
- Pages: 656-666
- First Published: 23 July 2010
Free Access
free
Biliary secretion of S-nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat†
- Pages: 667-677
- First Published: 23 July 2010
Free Access
free
Transgenic expression of cholesterol 7α-hydroxylase in the liver prevents high-fat diet–induced obesity and insulin resistance in mice†
- Pages: 678-690
- First Published: 23 July 2010
Free Access
free
CXC receptor-2 knockout genotype increases X-linked inhibitor of apoptosis protein and protects mice from acetaminophen hepatotoxicity†
- Pages: 691-702
- First Published: 23 July 2010
Free Access
free
Carbonyl reductase 1 as a novel target of (−)-epigallocatechin gallate against hepatocellular carcinoma†
- Pages: 703-714
- First Published: 23 July 2010
Special Articles
Free Access
free
What is critical for liver surgery and partial liver transplantation: Size or quality?†
- Pages: 715-729
- First Published: 23 July 2010
Meeting Report
Free Access
free
Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshop†‡
- Pages: 730-742
- First Published: 23 July 2010
Diagnostic and Therapeutic Advances in Hepatology
Reviews
Free Access
free
Pharmacogenetics of drug-induced liver injury†
- Pages: 748-761
- First Published: 23 July 2010
Free Access
free
Loco-regional treatment of hepatocellular carcinoma†
- Pages: 762-773
- First Published: 23 July 2010
Free Access
free
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†
- Pages: 774-788
- First Published: 23 July 2010
Hepatology Elsewhere
Free Access
free
Vitamin E for nonalcoholic steatohepatitis: Ready for prime time?†
- Pages: 789-792
- First Published: 23 July 2010
Free Access
free
Gut instinct: Rifaximin for the prevention of hepatic encephalopathy†
- Pages: 792-794
- First Published: 23 July 2010
Image of the Month
Free Access
free
An unusual cause of acute cholangitis†
- Pages: 795-796
- First Published: 23 July 2010
Correspondence
Free Access
free
“Nonalcoholic fatty liver disease” in a developing country: A different perspective†
- Page: 797
- First Published: 23 July 2010
Free Access
free
Antituberculosis therapy drug-induced liver injury and acute liver failure†
- Pages: 798-799
- First Published: 23 July 2010
Free Access
free
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantation†
- Pages: 800-801
- First Published: 23 July 2010
Free Access
free
Targeting heme oxygenase/adiponectin axis for chronic hepatitis C treatment†
- Page: 801
- First Published: 23 July 2010
Free Access
free
The curative efficiency of tenofovir for patients with chronic hepatitis B after failure of nucleoside/nucleotide analogues†
- Page: 802
- First Published: 23 July 2010
Free Access
free
Hepatitis B in refugees, guessing the prevalence†
- Pages: 802-803
- First Published: 23 July 2010
Free Access
free
Is cigarette smoking an independent risk factor or a cofactor for nonalcoholic fatty liver disease?†
- Pages: 803-804
- First Published: 23 July 2010
Free Access
free
Histological subclassification of cirrhosis†
- Page: 805
- First Published: 23 July 2010